BRIEF-Latigo Biotherapeutics Announces IPO Of Common Stock
Reuters2026/07/17 17:30July 17 (Reuters) - Latigo Biotherapeutics:
LATIGO BIOTHERAPEUTICS - ANNOUNCES INITIAL PUBLIC OFFERING OF COMMON STOCK - SEC FILING
LATIGO BIOTHERAPEUTICS - APPLIES TO LIST ON NASDAQ UNDER SYMBOL LTGO - SEC FILING
LATIGO BIOTHERAPEUTICS: GOLDMAN SACHS & CO. LLC, JEFFERIES, LEERINK PARTNERS, GUGGENHEIM SECURITIES ARE UNDERWRITERS TO IPO
Source text: [ID:n0001193125-26-307306]
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Elon Musk Grok AI Predicts Solana Could Hit $400+ By 2027
Investment in Canada’s mining sector to grow with global demand, BMO
Morgan Stanley Gives Huge Stock Market Crash Warning in 30 Days
Pundit Says This News Is Highly Bullish for Ripple and XRP
Crypto prices
More
